Impax Laboratories (IPXL) Shareholder Fosun International LTD Boosted Its Holding; As Credit Accep Mich (CACC) Market Valuation Rose, Shareholder Ancient Art LP Has Decreased Its Holding by $24.86 Million

February 21, 2018 - By Winifred Garcia

Fosun International Ltd increased its stake in Impax Laboratories Inc (IPXL) by 1185% based on its latest 2017Q3 regulatory filing with the SEC. Fosun International Ltd bought 3.55 million shares as the company’s stock rose 7.88% with the market. The institutional investor held 3.85M shares of the health care company at the end of 2017Q3, valued at $78.26M, up from 300,000 at the end of the previous reported quarter. Fosun International Ltd who had been investing in Impax Laboratories Inc for a number of months, seems to be bullish on the $1.47 billion market cap company. The stock increased 3.81% or $0.75 during the last trading session, reaching $20.45. About 389,425 shares traded. Impax Laboratories, Inc. (NASDAQ:IPXL) has declined 49.01% since February 21, 2017 and is downtrending. It has underperformed by 65.71% the S&P500.

Quincy Lee decreased its stake in Credit Accep Corp Mich (CACC) by 22.46% based on its latest 2017Q3 regulatory filing with the SEC. Ancient Art Lp sold 88,802 shares as the company’s stock rose 15.18% with the market. The hedge fund run by Quincy Lee held 306,547 shares of the consumer services company at the end of 2017Q3, valued at $85.89 million, down from 395,349 at the end of the previous reported quarter. Ancient Art Lp who had been investing in Credit Accep Corp Mich for a number of months, seems to be less bullish one the $6.26 billion market cap company. The stock increased 0.48% or $1.55 during the last trading session, reaching $322.26. About 13,080 shares traded. Credit Acceptance Corporation (NASDAQ:CACC) has risen 27.46% since February 21, 2017 and is uptrending. It has outperformed by 10.76% the S&P500.

Investors sentiment increased to 1.75 in 2017 Q3. Its up 0.85, from 0.9 in 2017Q2. It improved, as 14 investors sold IPXL shares while 39 reduced holdings. 39 funds opened positions while 54 raised stakes. 65.84 million shares or 4.79% more from 62.83 million shares in 2017Q2 were reported. Assetmark, a California-based fund reported 802 shares. Glenmede Na invested 0% in Impax Laboratories, Inc. (NASDAQ:IPXL). Metropolitan Life Communication Ny reported 51,945 shares or 0.01% of all its holdings. New York-based Pinebridge Invests LP has invested 0.05% in Impax Laboratories, Inc. (NASDAQ:IPXL). D E Shaw & reported 857,470 shares. 6,324 were accumulated by Ameritas Inv Prtn. Citadel Advsr Llc invested in 0% or 231,258 shares. The New York-based Oppenheimer Asset Mgmt Inc has invested 0% in Impax Laboratories, Inc. (NASDAQ:IPXL). Renaissance Lc owns 630,100 shares. Moreover, Voya Invest Mgmt Ltd Limited Liability Company has 0% invested in Impax Laboratories, Inc. (NASDAQ:IPXL) for 33,947 shares. Guggenheim Cap Ltd Liability holds 0.01% or 138,764 shares in its portfolio. 1.01M are held by Point72 Asset Lp. Canada Pension Plan Investment Board accumulated 45,000 shares. Credit Suisse Ag reported 0% stake. Panagora Asset Mgmt Inc has invested 0.01% in Impax Laboratories, Inc. (NASDAQ:IPXL).

Among 21 analysts covering Impax Laboratories Inc. (NASDAQ:IPXL), 6 have Buy rating, 2 Sell and 13 Hold. Therefore 29% are positive. Impax Laboratories Inc. had 47 analyst reports since July 21, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained Impax Laboratories, Inc. (NASDAQ:IPXL) on Wednesday, August 9 with “Buy” rating. The firm earned “Hold” rating on Monday, October 30 by BMO Capital Markets. As per Thursday, November 10, the company rating was maintained by RBC Capital Markets. Cantor Fitzgerald maintained Impax Laboratories, Inc. (NASDAQ:IPXL) on Monday, September 11 with “Overweight” rating. BMO Capital Markets maintained Impax Laboratories, Inc. (NASDAQ:IPXL) on Friday, September 29 with “Hold” rating. Susquehanna initiated it with “Positive” rating and $60 target in Tuesday, July 21 report. The stock has “Market Perform” rating by Northland Capital on Tuesday, April 19. The firm has “Sector Perform” rating given on Tuesday, February 23 by RBC Capital Markets. The stock has “Hold” rating by Cowen & Co on Friday, November 10. On Thursday, September 14 the stock rating was maintained by RBC Capital Markets with “Hold”.

Ancient Art Lp, which manages about $961.48 million and $533.62 million US Long portfolio, upped its stake in Fossil Group Inc (NASDAQ:FOSL) by 337,502 shares to 1.57 million shares, valued at $14.61 million in 2017Q3, according to the filing.

Since February 5, 2018, it had 0 insider purchases, and 1 sale for $319,860 activity.

Investors sentiment decreased to 1.03 in Q3 2017. Its down 0.27, from 1.3 in 2017Q2. It is negative, as 24 investors sold CACC shares while 49 reduced holdings. 29 funds opened positions while 46 raised stakes. 13.13 million shares or 4.29% less from 13.72 million shares in 2017Q2 were reported. State Of Wisconsin Investment Board accumulated 2,276 shares. Vanguard Grp holds 0.01% or 988,122 shares. 1.17M are owned by Abrams Bison Limited Liability Company. Laurion Cap Management LP owns 1,000 shares or 0% of their US portfolio. Sterling Capital Ltd Liability Com invested 0.01% in Credit Acceptance Corporation (NASDAQ:CACC). Jpmorgan Chase holds 0% or 14,659 shares. Macquarie Grp owns 900 shares. Northern Trust Corporation invested 0% of its portfolio in Credit Acceptance Corporation (NASDAQ:CACC). Mackenzie holds 22,622 shares or 0.03% of its portfolio. Ahl Partners Limited Liability Partnership holds 0.03% of its portfolio in Credit Acceptance Corporation (NASDAQ:CACC) for 5,171 shares. 1,236 are owned by Amer Century Cos Inc. Credit Suisse Ag reported 8,874 shares. Glob Endowment Mgmt Limited Partnership has invested 4.03% in Credit Acceptance Corporation (NASDAQ:CACC). Blackrock Inc owns 0.01% invested in Credit Acceptance Corporation (NASDAQ:CACC) for 478,152 shares. Lmr Ptnrs Llp reported 86,102 shares.

Analysts await Credit Acceptance Corporation (NASDAQ:CACC) to report earnings on May, 7. They expect $5.31 EPS, up 13.70% or $0.64 from last year’s $4.67 per share. CACC’s profit will be $103.07M for 15.17 P/E if the $5.31 EPS becomes a reality. After $5.16 actual EPS reported by Credit Acceptance Corporation for the previous quarter, Wall Street now forecasts 2.91% EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.